Repetitive transcranial magnetic stimulation for the treatment of suicidality in opioid use disorder: a pilot feasibility randomized controlled trial.

Saved in:
Bibliographic Details
Title: Repetitive transcranial magnetic stimulation for the treatment of suicidality in opioid use disorder: a pilot feasibility randomized controlled trial.
Authors: Tang VM; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada., Le Foll B; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Translational Addiction Research Laboratory, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada.; Waypoint Research Institute, Waypoint Centre for Mental Health Care, Penetanguishene, ONCanada., Daskalakis ZJ; Department of Psychiatry, University of California, San Diego, CA, USA., Wang AL; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Buckley L; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Addictions Division, Centre for Addiction and Mental Health, Toronto, ON, Canada., Blumberger DM; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada., Voineskos D; Institute of Medical Science, University of Toronto, Toronto, ON, Canada.; Department of Psychiatry, Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, ON, Canada.; Poul Hansen Family Centre for Depression, Krembil Research Institute, Toronto Western Hospital, University Health Network, Toronto, ON, Canada.
Source: European psychiatry : the journal of the Association of European Psychiatrists [Eur Psychiatry] 2025 Mar 05; Vol. 68 (1), pp. e63. Date of Electronic Publication: 2025 Mar 05.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9111820 Publication Model: Electronic Cited Medium: Internet ISSN: 1778-3585 (Electronic) Linking ISSN: 09249338 NLM ISO Abbreviation: Eur Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1778-3585
DOI:10.1192/j.eurpsy.2025.28